Percutaneous Endoscopic Gastrostomy — черезшкірна ендоскопічна гастростомія. From long-term enteral access indication through pull-technique placement, risk screening, and post-procedure stoma care.
A nasogastric (NG) tube is a fast, bedside solution for short-term enteral access — but it is uncomfortable, prone to dislodgement, carries aspiration and nasal/sinus complication risk, and is not designed for prolonged use. When clinical judgment anticipates enteral nutrition support extending beyond a few weeks (commonly cited as roughly 2–4 weeks), a percutaneous endoscopic gastrostomy (PEG) becomes the more durable, better-tolerated option for delivering feeds, fluids, and medications directly into the stomach.
Enteral access decisions follow a simple logic: match the invasiveness of the access route to the expected duration and reversibility of the swallowing/nutrition problem.
Nasogastric (NG) / orogastric tubes: • Placed at bedside without sedation or imaging (radiographic confirmation still required) • Ideal bridge for days-to-a-few-weeks: acute stroke dysphagia under evaluation, post-operative ileus, short ICU courses • Downsides accumulate with time: nasal/pharyngeal erosion, sinusitis, tube migration or self-removal, patient discomfort, and social/body-image burden • Aspiration risk is not eliminated by NG placement and may be compounded by tube-related reflux
Percutaneous endoscopic gastrostomy (PEG): • Requires a short endoscopic procedure but yields a low-profile, more secure, better-tolerated long-term access route • Appropriate once the clinical team anticipates enteral support will be needed beyond the short-term window — classic examples include progressive neurodegenerative disease (ALS/MND), major stroke with persistent dysphagia, and head & neck cancer patients undergoing radiotherapy • Not first-line for patients expected to recover oral intake within a few weeks, nor for patients with a prognosis too limited to benefit from the procedure
The decision is never purely time-based — functional prognosis, patient/family goals of care, and procedural risk all factor in — but anticipated duration remains the dominant trigger that prompts the conversation about converting from NG to PEG.
Before consenting a patient for PEG placement, teams typically confirm:
• A functioning, accessible stomach and an expectation that enteral (rather than parenteral) feeding is appropriate • A realistic chance the patient will benefit from weeks-to-months (or permanent) enteral access • No absolute contraindication such as inability to appose the anterior gastric wall to the abdominal wall, complete gastric outlet obstruction, or uncorrectable coagulopathy • Speech-language pathology and dietitian input confirming oral intake is genuinely unsafe or insufficient • Documented discussion of goals of care — PEG in advanced dementia, for instance, has not been shown to improve survival or reduce aspiration pneumonia in numerous studies, so indication is individualized rather than automatic
The pull technique, described by Gauderer, Ponsky, and Izant in 1980, remains the most widely used method for PEG placement worldwide. It couples endoscopic visualization of the stomach from within with percutaneous access from the abdominal wall, using a guidewire "railroad" to draw the gastrostomy tube into its final position without open surgery.
1. Endoscope insertion and gastric insufflation: • The endoscope is passed through the mouth, esophagus, and into the stomach • Air insufflation distends the stomach, pressing the anterior gastric wall against the abdominal wall — essential for safe puncture
2. Transillumination and finger indentation: • The room is dimmed; the endoscopist looks for a bright spot of light shining through the abdominal wall from the endoscope inside the stomach — confirming no bowel or solid organ interposition • An assistant presses a finger on the abdominal wall; the endoscopist confirms a corresponding indentation is visible on the gastric mucosa, verifying safe apposition
3. Percutaneous needle/cannula puncture: • Local anesthetic is infiltrated; a needle-and-cannula assembly is passed through the abdominal wall directly into the insufflated stomach under direct endoscopic view
4. Guidewire passage and snare capture: • A guidewire is threaded through the cannula into the stomach • The endoscopist grasps the wire with a snare or forceps passed through the endoscope
5. Withdrawal of endoscope with wire, out through the mouth: • The endoscope, snare, and guidewire are withdrawn together back up the esophagus and out the mouth, so the guidewire now spans from the abdominal wall, through the stomach and esophagus, and out the mouth
6. Tube attachment and the "pull": • The tapered leading end of the PEG tube (with its internal bumper) is tied or clipped to the oral end of the guidewire • Traction is applied at the abdominal wall end, pulling the wire — and with it the entire PEG tube — back down through the mouth, esophagus, and stomach, and out through the abdominal wall puncture
7. Final seating and endoscopic confirmation: • The internal bumper is drawn snugly against the inner gastric wall • A second endoscope pass (or the same scope reinserted) confirms correct bumper position and that the mucosa is not excessively compressed • An external bumper/flange is fitted at the skin, and the tube is cut and fitted with a feeding adapter
The transillumination and finger-indentation checks are the single most important safety steps in the pull technique — they exist specifically to avoid inadvertent puncture of colon, small bowel, liver, or spleen interposed between the stomach and abdominal wall.
A tube could in principle be pushed directly through a puncture into the stomach (this is essentially what the introducer/Russell technique does, using balloon-retained tubes rather than a mushroom-shaped bumper). The pull technique instead routes the tube through the mouth because:
• The internal bumper is typically a rigid mushroom/dome shape too large to pass through the narrow percutaneous tract directly — but it passes easily down the wide esophagus • Guiding the tube via the natural lumen avoids forcing a wide bumper through abdominal wall tissue, reducing tissue trauma and bleeding • It allows direct endoscopic visualization of the tube seating correctly against the gastric mucosa before the case ends
The trade-off is that the tube passes through the oropharynx, so the pull technique is avoided in patients with obstructing oropharyngeal or esophageal tumors that would prevent tube passage — the introducer technique is preferred in that setting instead.
Because PEG placement combines an endoscopic procedure with a percutaneous puncture through the abdominal wall into the stomach, pre-procedure assessment specifically screens for bleeding risk, anatomic factors that complicate safe gastric-to-abdominal-wall apposition, and whether the patient is stable enough to tolerate sedation and the procedure itself.
Because the procedure requires a full-thickness gastric and abdominal wall puncture, bleeding risk assessment mirrors that of other high-bleeding-risk endoscopic procedures:
• Coagulation studies (INR, platelet count) are checked and corrected toward target ranges before proceeding • Anticoagulants (warfarin, direct oral anticoagulants) are typically held for an appropriate interval pre-procedure per society guidance, with bridging considered case-by-case for high thromboembolic-risk patients • Antiplatelet agents beyond low-dose aspirin (e.g., clopidogrel) are often held when clinically feasible • Uncorrectable severe coagulopathy is a relative-to-absolute contraindication until corrected
Safe transillumination and apposition of the gastric wall to the abdominal wall can be prevented or complicated by:
• Ascites — fluid separates the stomach from the abdominal wall, preventing safe apposition and increasing leak/peritonitis risk unless drained or managed first • Gastric varices or portal hypertensive gastropathy — increases bleeding risk at the puncture site • Prior abdominal/gastric surgery — altered anatomy, interposed bowel, or adhesions can obscure the safe puncture window • Hepatomegaly or splenomegaly — organ interposition between stomach and abdominal wall • Morbid obesity — a thick abdominal wall can make transillumination difficult to visualize and increases tract length • Active peritonitis or bowel obstruction — generally an absolute contraindication
When transillumination or finger-indentation cannot be clearly confirmed, the procedure should be aborted or converted to an image-guided (fluoroscopic/CT) or surgical gastrostomy approach rather than proceeding blindly.
Because most PEG placements are performed under conscious/moderate sedation, patients are also screened for:
• Hemodynamic stability and adequate respiratory reserve to tolerate sedation and endoscopy • Active infection or sepsis that should be addressed before an elective procedure • Realistic short-term prognosis — placing a PEG in a patient who is imminently dying does not benefit the patient and exposes them to unnecessary procedural risk • Baseline nutritional and metabolic status, since severely malnourished patients are at higher risk of refeeding syndrome once feeding begins
When risk factors are identified, mitigation options include correcting coagulopathy, draining ascites first, choosing the introducer/Russell technique or a radiologically-guided gastrostomy instead of the endoscopic pull technique, or deferring the procedure until the patient is more stable.
Pre-procedure screening exists to shift risk mitigation earlier: correcting a coagulopathy or draining ascites before the scope touches the patient is far safer than managing a bleed or peritonitis after the tube is already placed.
Immediately after placement, the gastric and abdominal walls are held in apposition by the internal bumper and external flange, but the tract between them has not yet matured. Early post-procedure care focuses on protecting that fresh tract, monitoring the site, and observing a defined interval before the tube is used for feeding.
In the first 24–48 hours:
• A dry sterile dressing typically covers the site initially, changed if soiled or per protocol • The external bumper/disc should sit snugly against the skin — a few millimeters of "give" (often described as the width of one gauze) prevents excessive tension that could cause pressure necrosis, while too much slack allows the tube to shift and destabilize the tract • The site is inspected for excessive bleeding, leakage of gastric contents, or early signs of infection • The tube is secured to prevent traction or accidental dislodgement, which in the first 1–2 weeks (before the tract has matured/epithelialized) can allow the stomach to separate from the abdominal wall — a serious early complication requiring urgent reassessment
Although the tube is mechanically in place at the end of the procedure, feeding is typically deferred for a defined interval — commonly around 24 hours, though practice varies by institution — before the new tract is used. This allows:
• Initial hemostasis and local tissue apposition/early adhesion to begin forming between the gastric serosa and peritoneal surface of the abdominal wall • Recovery from sedation and confirmation of return of bowel function • A window to observe for early complications (bleeding, peritoneal signs, respiratory issues from sedation) before introducing feeds
Some contemporary protocols support earlier feeding (a few hours post-procedure) in uncomplicated cases, reflecting evolving evidence that very early feeding does not meaningfully increase complication rates — but a defined observation interval before the first feed remains standard practice, and the exact timing is guided by institutional protocol and the patient's clinical course.
Waiting for an initial post-procedure interval before feeding is a tract-stabilization safety step, not an arbitrary rule — introducing feeds too early into an immature tract raises the risk that gastric contents leak into the peritoneal space rather than staying confined to the tube.
Once cleared to begin:
• Feeds are typically started at a low rate/volume and advanced gradually toward the target regimen over 1–2 days, with attention to tolerance (nausea, distension, high gastric residuals) • The tube is flushed with water before and after each feed and medication dose to prevent clogging • Medications are given in liquid form when possible, or crushed tablets fully dissolved, to reduce the risk of tube obstruction • Patients/caregivers receive education on feeding schedule, tube flushing, site care, and the signs that warrant contacting the care team
Once the stoma tract matures (typically by 1–2 weeks), long-term PEG management shifts from protecting a fresh wound to routine maintenance: daily site cleaning, periodic tube rotation/repositioning, and ongoing vigilance for complications that can develop weeks to months after placement — most notably peristomal infection and buried bumper syndrome.
Once the tract has matured, day-to-day care is comparatively simple:
• Daily cleaning of the skin around the stoma with mild soap and water, then thorough drying — a dressing is usually no longer required over a healed site • Checking that the external bumper remains snug but not tight against the skin • Rotating the tube a full 360° once daily (for bumper-type tubes, per manufacturer/institutional protocol) and gently advancing/retracting it slightly to prevent the internal bumper from adhering to and eroding into the gastric mucosa • Periodic tube replacement (balloon-retained tubes typically every 3–6 months; bumper-retained tubes are usually changed less frequently or only when malfunctioning) • Confirming balloon volume periodically for balloon-retained (not endoscopically placed bumper) replacement tubes, since balloons slowly lose fluid over time
Peristomal (stoma site) infection is among the most common PEG complications, ranging from minor cellulitis to (rarely) necrotizing fasciitis in severe cases.
Signs to recognize: • Increasing redness, warmth, or swelling extending outward from the stoma • Purulent drainage, foul odor, or increasing pain at the site • Fever or systemic signs of infection • "Buttoning" of granulation tissue can be mistaken for infection but is a distinct benign overgrowth response
Management is generally stepwise: local wound care and closer monitoring for mild cases, topical or oral antibiotics for cellulitis, and prompt escalation (imaging, IV antibiotics, surgical evaluation) if there is any suspicion of deeper spread or necrotizing infection. Risk is reduced by single-dose prophylactic antibiotics at the time of placement, meticulous technique, and good ongoing site hygiene.
Buried bumper syndrome occurs when the internal bumper migrates out of the gastric lumen and becomes embedded within the gastric wall or, in advanced cases, the abdominal wall tissue between stomach and skin — usually from excessive external tension on the tube over time, or failure to rotate/mobilize it as recommended.
Warning signs: • Increasing resistance when rotating or advancing the tube • Difficulty flushing, or feeds leaking around the tube • Pain with feeding, or the external bumper appearing to sit closer to the skin than before • In advanced cases, the internal bumper may be undetectable on attempted endoscopic visualization
Other recognized long-term complications include peristomal leakage (gastric contents tracking around the tube, causing skin irritation), tube clogging or accidental dislodgement, granulation tissue overgrowth, and — rarely — tumor seeding along the tract in patients with head & neck malignancy.
Management of buried bumper syndrome typically requires endoscopic or surgical removal/release of the embedded bumper and, if the tract remains viable, replacement with a new tube; if not, the tract may need to be allowed to close and reformed.
Daily tube rotation and monitoring bumper snugness are simple habits that directly prevent the two most consequential long-term complications — buried bumper syndrome and pressure-related peristomal breakdown — making routine care, not just the procedure itself, central to PEG safety.